1Department of Neurosurgery, Charité-Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin.
2Department of Neurosurgery, School of Medicine, Klinikum rechts der Isar, Technical University of Munich.
Neurosurg Focus. 2021 May;50(5):E7. doi: 10.3171/2021.2.FOCUS201067.
Surgical management of spinal metastases at the cervicothoracic junction (CTJ) is highly complex and relies on case-based decision-making. The aim of this multicentric study was to describe surgical procedures for metastases at the CTJ and provide guidance for clinical and surgical management.
Patients eligible for this study were those with metastases at the CTJ (C7-T2) who had been consecutively treated in 2005-2019 at 7 academic institutions across Europe. The Spine Instability Neoplastic Score, neurological function, clinical status, medical history, and surgical data for each patient were retrospectively assessed. Patients were divided into four surgical groups: 1) posterior decompression only, 2) posterior decompression and fusion, 3) anterior corpectomy and fusion, and 4) anterior corpectomy and 360° fusion. Endpoints were complications, surgical revision rate, and survival.
Among the 238 patients eligible for inclusion this study, 37 were included in group 1 (15%), 127 in group 2 (53%), 18 in group 3 (8%), and 56 in group 4 (24%). Mechanical pain was the predominant symptom (79%, 189 patients). Surgical complications occurred in 16% (group 1), 20% (group 2), 11% (group 3), and 18% (group 4). Of these, hardware failure (HwF) occurred in 18% and led to surgical revision in 7 of 8 cases. The overall complication rate was 34%. In-hospital mortality was 5%.
Posterior fusion and decompression was the most frequently used technique. Care should be taken to choose instrumentation techniques that offer the highest possible biomechanical load-bearing capacity to avoid HwF. Since the overall complication rate is high, the prevention of in-hospital complications seems crucial to reduce in-hospital mortality.
颈椎胸段交界区(CTJ)脊柱转移瘤的外科治疗非常复杂,依赖于基于病例的决策。本多中心研究的目的是描述 CTJ 转移瘤的手术治疗方法,并为临床和外科治疗提供指导。
本研究纳入了 2005 年至 2019 年期间在欧洲 7 家学术机构连续治疗的 CTJ(C7-T2)转移瘤患者。回顾性评估每位患者的脊柱不稳定肿瘤评分、神经功能、临床状况、病史和手术数据。将患者分为 4 个手术组:1)单纯后路减压,2)后路减压融合,3)前路椎体切除术和融合,4)前路椎体切除术和 360°融合。终点是并发症、手术翻修率和生存率。
本研究共纳入 238 例符合条件的患者,其中 37 例纳入组 1(15%),127 例纳入组 2(53%),18 例纳入组 3(8%),56 例纳入组 4(24%)。主要症状为机械性疼痛(79%,189 例)。组 1 发生手术并发症 16%(6 例),组 2 20%(26 例),组 3 11%(2 例),组 4 18%(10 例)。其中,发生 18%(组 1)的硬件失败(HwF),导致 7 例需手术翻修。总体并发症发生率为 34%。院内死亡率为 5%。
后路融合和减压是最常用的技术。应注意选择具有最高生物力学承载能力的器械技术,以避免 HwF。由于总体并发症发生率较高,预防院内并发症似乎对降低院内死亡率至关重要。